2023 World Conference on Lung Cancer (Posters)-EP17.04. Global, Regional, National Burden of Lung Cancer Attributable to High Fasting Plasma Glucose

EP17.04. Global, Regional, National Burden of Lung Cancer Attributable to High Fasting Plasma Glucose - PDF(Slides)

Pdf Summary

A study conducted by Minmin Wang of Peking University in China analyzed the global burden of lung cancer attributable to high fasting plasma glucose (HFPG). Lung cancer is a leading cause of cancer death worldwide, and there is evidence that metabolic disorders, such as diabetes, are associated with an increased risk of developing and having a poor prognosis for lung cancer. The study aimed to provide evidence for the development of integrated lung cancer prevention strategies.<br /><br />The data for the study was sourced from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019. The study used various estimation frameworks to determine the burden of lung cancer attributable to HFPG. This included analyzing relative risks based on systematic reviews, exposure to risk factors based on population survey data, and computing the attributable disease burden.<br /><br />The results of the study showed that the burden of lung cancer attributable to HFPG has increased globally from 1990 to 2019. The burden is higher in men compared to women and increases with age, peaking at above 70 years. The study also found a positive correlation between the burden of lung cancer attributable to HFPG and social development levels.<br /><br />These findings highlight the importance of addressing metabolic disorders, such as HFPG, as a key element in integrated cancer prevention and control measures. The study calls for efforts to control metabolic disorders and develop strategies that can effectively reduce the burden of lung cancer attributable to HFPG.

Asset Subtitle

Minmin Wang

Meta Tag

Speaker Minmin Wang

Topic Global Health, Health Services & Health Economics: Real World Data

Keywords

lung cancer

high fasting plasma glucose

metabolic disorders

diabetes

cancer death

poor prognosis

integrated lung cancer prevention strategies

Global Burden of Diseases

relative risks

exposure to risk factors